VSTM
Closed
Verastem Inc
2.4
0.0 (0.00%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 2.4
Day's Range: 2.34 - 2.45
Send
sign up or login to leave a comment!
When Written:
0.3899
Verastem Inc is a biopharmaceutical company that focuses on developing drugs to treat cancer. The company was founded in 2010 and is headquartered in Needham, Massachusetts. Verastem's main focus is on developing small molecule drugs that target cancer stem cells, which are believed to be responsible for the growth and spread of cancer. The company's lead product candidate, VS-6063, is currently in clinical trials for the treatment of mesothelioma, ovarian cancer, and other solid tumors. Verastem has also developed a diagnostic test called COPIKTRA, which is used to identify patients with chronic lymphocytic leukemia and small lymphocytic lymphoma who are likely to respond to treatment with a specific class of drugs. The company is publicly traded on the NASDAQ exchange under the ticker symbol VSTM.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!